Comparison of the Effects of Sugammadex Recommended Dose (2 mg/kg) and Fixed Dose of 200 mg on the Reversal of Moderate Neuromuscular Block and Recovery Profile in Adult Patients
<i>Background and Objectives</i>: Neuromuscular blocking agents are essential to ensure optimal surgical conditions during general anesthesia. Sugammadex, a selective binding agent, is widely used to reverse neuromuscular blockade. While weight-based dosing (2 mg/kg for moderate blockade...
Saved in:
| Main Authors: | Ji-Yoon Jung, Sung-Ae Cho, Woojin Kwon, Hongwook Kim, Tae-Yun Sung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/1/151 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Current evidence on the use of sugammadex for neuromuscular blockade antagonism during electroconvulsive therapy: a narrative review
by: Vivek Arora, et al.
Published: (2025-02-01) -
Neuromuscular blockade in anaesthesia for maxillofacial cancer surgery: specifics, advantages, challenges and solutions (literary review)
by: T. E. Selina, et al.
Published: (2025-07-01) -
Effects of sugammadex on coagulation: a systematic review and meta-analysis
by: Yu-Hsun Tsai, et al.
Published: (2025-04-01) -
Sugammadex or neostigmine for reversal of neuromuscular block on the quality of postoperative recovery in elderly adults undergoing video-assisted thoracoscopic lobectomy: a randomised controlled trial
by: Yu Yang, et al.
Published: (2025-05-01) -
Decurarization After Thoracic Anesthesia using sugammadex compared to neostigmine (DATA trial): a multicenter randomized double-blinded controlled trial
by: Federico Piccioni, et al.
Published: (2024-02-01)